These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26523653)

  • 1. Intramyocellular lipid content in subjects with impaired fasting glucose after telmisartan treatment, a randomised cross-over trial.
    Kratochvílová S; Škoch A; Wohl P; Švehlíková E; Dezortová M; Hill M; Hájek M; Pelikánová T
    Magn Reson Imaging; 2016 Apr; 34(3):353-8. PubMed ID: 26523653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose.
    Wohl P; Krusinová E; Hill M; Kratochvílová S; Zídková K; Kopecký J; Neskudla T; Pravenec M; Klementová M; Vrbíková J; Wohl P; Mlejnek P; Pelikánová T
    Eur J Endocrinol; 2010 Oct; 163(4):573-83. PubMed ID: 20630944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial.
    Chetty VT; Damjanovic S; Gerstein H; Singh N; Yusuf S; Anand SS; Sharma AM
    Blood Press; 2014 Feb; 23(1):54-60. PubMed ID: 23731019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
    Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.
    Jacob S; Machann J; Rett K; Brechtel K; Volk A; Renn W; Maerker E; Matthaei S; Schick F; Claussen CD; Häring HU
    Diabetes; 1999 May; 48(5):1113-9. PubMed ID: 10331418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects.
    Nagel JM; Tietz AB; Göke B; Parhofer KG
    Metabolism; 2006 Sep; 55(9):1149-54. PubMed ID: 16919531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and Type 2 diabetic Asian Northern Indian males: high intramyocellular lipid content correlates with excess body fat and abdominal obesity.
    Misra A; Sinha S; Kumar M; Jagannathan NR; Pandey RM
    Diabet Med; 2003 May; 20(5):361-7. PubMed ID: 12752484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes.
    Perseghin G; Lattuada G; Danna M; Sereni LP; Maffi P; De Cobelli F; Battezzati A; Secchi A; Del Maschio A; Luzi L
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1174-81. PubMed ID: 12933352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy shows an inverse correlation between intramyocellular lipid content in human calf muscle and local glycogen synthesis rate.
    van der Graaf M; Tack CJ; de Haan JH; Klomp DW; Heerschap A
    NMR Biomed; 2010 Feb; 23(2):133-41. PubMed ID: 19739109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.
    Schrauwen-Hinderling VB; Kooi ME; Hesselink MK; Jeneson JA; Backes WH; van Echteld CJ; van Engelshoven JM; Mensink M; Schrauwen P
    Diabetologia; 2007 Jan; 50(1):113-20. PubMed ID: 17093944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
    Fogari R; Zoppi A; Ferrari I; Mugellini A; Preti P; Lazzari P; Derosa G
    Horm Metab Res; 2009 Dec; 41(12):893-8. PubMed ID: 19708000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.
    Krssak M; Falk Petersen K; Dresner A; DiPietro L; Vogel SM; Rothman DL; Roden M; Shulman GI
    Diabetologia; 1999 Jan; 42(1):113-6. PubMed ID: 10027589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan and metabolic syndrome after heart transplantation.
    Luknar M; Goncalvesova E; Lesny P; Fabian J
    Clin Transplant; 2010; 24(1):36-9. PubMed ID: 19222503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In-vivo 1H-MR spectroscopy: the determination of the intra- and extramyocellular lipid content depending on the insulin effect in the direct offspring of type-2 diabetics].
    Brechtel K; Machann J; Jacob S; Strempfer A; Schick F; Häring HU; Claussen CD
    Rofo; 1999 Aug; 171(2):113-20. PubMed ID: 10506884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.
    Lattuada G; Costantino F; Caumo A; Scifo P; Ragogna F; De Cobelli F; Del Maschio A; Luzi L; Perseghin G
    Diabetologia; 2005 Apr; 48(4):741-7. PubMed ID: 15759111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients.
    Negro R; Formoso G; Hassan H
    J Endocrinol Invest; 2006 Dec; 29(11):957-61. PubMed ID: 17259791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.
    Kotronen A; Seppälä-Lindroos A; Bergholm R; Yki-Järvinen H
    Diabetologia; 2008 Jan; 51(1):130-8. PubMed ID: 18008059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle.
    Virkamäki A; Korsheninnikova E; Seppälä-Lindroos A; Vehkavaara S; Goto T; Halavaara J; Häkkinen AM; Yki-Järvinen H
    Diabetes; 2001 Oct; 50(10):2337-43. PubMed ID: 11574417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation.
    Perseghin G; Lattuada G; De Cobelli F; Esposito A; Belloni E; Canu T; Ragogna F; Scifo P; Del Maschio A; Luzi L
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4883-8. PubMed ID: 17986645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.
    Perl S; Schmölzer I; Sourij H; Pressl H; Eder M; Zweiker R; Wascher TC
    Int J Cardiol; 2010 Mar; 139(3):289-96. PubMed ID: 19118910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.